EyePoint Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • EyePoint Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -43 %, a 68.8% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Return On Equity for 2023 was -61.5 %, a 17.2% increase from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Return On Equity for 2022 was -74.2 %, a 58.8% decline from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Return On Equity for 2021 was -46.8 %, a 87.9% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -43 +94.8 +68.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -43.2 +71.8 +62.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 -49.9 +38.7 +43.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -61.5 +12.8 +17.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 -138 -88.9 -181% Jul 1, 2023 Sep 30, 2023
Q2 2023 -115 -63.7 -124% Apr 1, 2023 Jun 30, 2023
Q1 2023 -88.6 -39.9 -81.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -74.2 -27.5 -58.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -49 +16.3 +24.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -51.4 +15.4 +23.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -48.7 +73.2 +60% Jan 1, 2022 Mar 31, 2022
Q4 2021 -46.8 +341 +87.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -65.2 +376 +85.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -66.8 +398 +85.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -122 +172 +58.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -388 -74 -23.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -441 -213 -93.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -464 -238 -105% Apr 1, 2020 Jun 30, 2020
Q1 2020 -294 +42.4 +12.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -314 +13.4 +4.11% Oct 1, 2019 Dec 31, 2019
Q3 2019 -228 +186 +45% Jul 1, 2019 Sep 30, 2019
Q2 2019 -226 +322 +58.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -337 -90.8 -36.9% Jan 1, 2019 Mar 31, 2019
Q4 2018 -327 -122 -59.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -415 -275 -197% Jul 1, 2018 Sep 30, 2018
Q2 2018 -548 -414 -307% Apr 1, 2018 Jun 30, 2018
Q1 2018 -246 -126 -105% Jan 1, 2018 Mar 31, 2018
Q4 2017 -206 -108 -111% Oct 1, 2017 Dec 31, 2017
Q3 2017 -140 -14.7 -11.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 -135 -27.8 -26% Apr 1, 2017 Jun 30, 2017
Q1 2017 -120 -22.4 -23% Jan 1, 2017 Mar 31, 2017
Q4 2016 -97.5 -1.56 -1.63% Oct 1, 2016 Dec 31, 2016
Q3 2016 -125 -50 -66.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -107 -128 -602% Apr 1, 2016 Jun 30, 2016
Q1 2016 -97.7 -125 -460% Jan 1, 2016 Mar 31, 2016
Q4 2015 -96 -137 -335% Oct 1, 2015 Dec 31, 2015
Q3 2015 -74.9 -128 -240% Jul 1, 2015 Sep 30, 2015
Q2 2015 21.3 +110 Apr 1, 2015 Jun 30, 2015
Q1 2015 27.2 +128 Jan 1, 2015 Mar 31, 2015
Q4 2014 40.8 +163 Oct 1, 2014 Dec 31, 2014
Q3 2014 53.4 +164 Jul 1, 2014 Sep 30, 2014
Q2 2014 -88.9 +8.44 +8.67% Apr 1, 2014 Jun 30, 2014
Q1 2014 -101 -26.4 -35.4% Jan 1, 2014 Mar 31, 2014
Q4 2013 -122 -53.5 -78.3% Oct 1, 2013 Dec 31, 2013
Q3 2013 -111 +47.1 +29.8% Jul 1, 2013 Sep 30, 2013
Q2 2013 -97.3 +23.5 +19.5% Apr 1, 2013 Jun 30, 2013
Q1 2013 -74.5 +11.2 +13.1% Jan 1, 2013 Mar 31, 2013
Q4 2012 -68.3 Oct 1, 2012 Dec 31, 2012
Q3 2012 -158 Jul 1, 2012 Sep 30, 2012
Q2 2012 -121 Apr 1, 2012 Jun 30, 2012
Q1 2012 -85.7 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.